2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005310239 (hide)

Owner Merck & Co., Inc.

Inventors Stachel, Shawn J.; Holloway, M. Katharine; Coburn, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005310239

PCT Pub. Number WO2006/060109

Priority 60/623,441 29.10.04 US

Filing date 25 October 2005

Wipo publication date 8 June 2006

International Classifications

C07D 211/72 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/060109 Priority application(s): WO2006/060109

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005310240-Process for preparing {3-[2(R)-[(1R)-1-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(S)-(4-fluorophenyl)mo rpholin4-yl]methyl]-5-oxo-4,5-dihydro-[1,2,4]-tri azol-1-yl}phosphonic acid

2005310238-N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators